menu
    • menu
    [{"orgOrder":0,"company":"University of Iceland","sponsor":"Mat\u00eds ohf | Reykjalundur Rehabilitation Center | Primex ehf","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"ICELAND","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Chitosan Hydrochloride","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"University of Iceland","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Capsule","sponsorNew":"University of Iceland \/ Mat\u00eds ohf | Reykjalundur Rehabilitation Center | Primex ehf","highestDevelopmentStatusID":"1","companyTruncated":"University of Iceland \/ Mat\u00eds ohf | Reykjalundur Rehabilitation Center | Primex ehf"}]

    Find Clinical Drug Pipeline Developments & Deals for Chitosan Hydrochloride

    Menu

    Chitosan Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University of Iceland

                            Country arrow
                            FNCE
                            Not Confirmed

                            University of Iceland

                            Country arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Chitosan Hydrochloride

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Undisclosed

                            Sponsor : Matís ohf | Reykjalundur Rehabilitation Center | Primex ehf

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            MicroFIBERgut: Effects of Lifestyle Changes and Chitosan on Gut Microbiota and Weight Management

                            Details : Chitosan is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            September 16, 2020

                            Lead Product(s) : Chitosan Hydrochloride

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Undisclosed

                            Sponsor : Matís ohf | Reykjalundur Rehabilitation Center | Primex ehf

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth